La Financiere de L'Echiquier’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-60,501
Closed -$4.01M – 94
2022
Q1
$4.01M Sell
60,501
-106,000
-64% -$7.25M 0.17% 65
2021
Q4
$16.7M Sell
166,501
-532
-0.3% -$55K 0.56% 47
2021
Q3
$20.9M Sell
167,033
-12,800
-7% -$1.52M 0.7% 46
2021
Q2
$22.3M Sell
179,833
-1,366
-0.8% -$184K 0.85% 39
2021
Q1
$27.7M Buy
181,199
+104,334
+136% +$15.8M 1.12% 39
2020
Q4
$9.91M Buy
76,865
+43,269
+129% +$4.98M 0.47% 50
2020
Q3
$3.76M Buy
33,596
+13,770
+69% +$1.26M 0.26% 48
2020
Q2
$1.61M Buy
19,826
+11,220
+130% +$904K 0.13% 51
2020
Q1
$599K Buy
8,606
+5,047
+142% +$387K 0.07% 49
2019
Q4
$278K Buy
+3,559
New +$256K 0.03% 53

Other funds holding GH

La Financiere de L'Echiquier's GH Position: Q2 2022 in Review

La Financiere de L'Echiquier sold out of Guardant Health (GH) in Q2 2022, closing a stake of 60,501 shares — an estimated $4.01M sold.

La Financiere de L'Echiquier first reported a position in GH in Q4 2019 and held it in 10 quarters. The position peaked at $27.7M in Q1 2021. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

  • La Financiere de L'Echiquier reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
  • La Financiere de L'Echiquier sold 60,501 Guardant Health shares in Q2 2022, an estimated $4.01M.
  • La Financiere de L'Echiquier first reported a position in Guardant Health in Q4 2019 and held it in 10 quarters.
  • La Financiere de L'Echiquier's Guardant Health position peaked at $27.7M in Q1 2021.
  • 332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on La Financiere de L'Echiquier's 13F filing for Q2 2022, filed 5 Aug 2022.